309 related articles for article (PubMed ID: 35660038)
1. Nanomedicine to deliver biological macromolecules for treating COVID-19.
Wilson B; Mukundan Geetha K
Vaccine; 2022 Jun; 40(29):3931-3941. PubMed ID: 35660038
[TBL] [Abstract][Full Text] [Related]
2. An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19.
Yasamineh S; Kalajahi HG; Yasamineh P; Yazdani Y; Gholizadeh O; Tabatabaie R; Afkhami H; Davodabadi F; Farkhad AK; Pahlevan D; Firouzi-Amandi A; Nejati-Koshki K; Dadashpour M
J Nanobiotechnology; 2022 Oct; 20(1):440. PubMed ID: 36209089
[TBL] [Abstract][Full Text] [Related]
3. Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy.
Mirtaleb MS; Mirtaleb AH; Nosrati H; Heshmatnia J; Falak R; Zolfaghari Emameh R
Biomed Pharmacother; 2021 Jun; 138():111518. PubMed ID: 33774315
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19.
Vahedifard F; Chakravarthy K
Emergent Mater; 2021; 4(1):75-99. PubMed ID: 33615140
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects.
Varahachalam SP; Lahooti B; Chamaneh M; Bagchi S; Chhibber T; Morris K; Bolanos JF; Kim NY; Kaushik A
Int J Nanomedicine; 2021; 16():539-560. PubMed ID: 33519200
[TBL] [Abstract][Full Text] [Related]
6. Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.
Milane L; Amiji M
Drug Deliv Transl Res; 2021 Aug; 11(4):1309-1315. PubMed ID: 33512669
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine strategies to target coronavirus.
Heinrich MA; Martina B; Prakash J
Nano Today; 2020 Dec; 35():100961. PubMed ID: 32904707
[TBL] [Abstract][Full Text] [Related]
8. Application of Nanotechnology in the COVID-19 Pandemic.
Yang D
Int J Nanomedicine; 2021; 16():623-649. PubMed ID: 33531805
[TBL] [Abstract][Full Text] [Related]
9. Recent updates on liposomal formulations for detection, prevention and treatment of coronavirus disease (COVID-19).
Dini Fatini Mohammad Faizal N; Cairul Iqbal Mohd Amin M
Int J Pharm; 2023 Jan; 630():122421. PubMed ID: 36410670
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19.
Rahman MM; Ahmed M; Islam MT; Khan MR; Sultana S; Maeesa SK; Hasan S; Hossain MA; Ferdous KS; Mathew B; Rauf A; Uddin MS
Curr Pharm Des; 2022; 28(12):948-968. PubMed ID: 34218774
[TBL] [Abstract][Full Text] [Related]
11. Chitosan and its derivatives as polymeric anti-viral therapeutics and potential anti-SARS-CoV-2 nanomedicine.
Tan RSL; Hassandarvish P; Chee CF; Chan LW; Wong TW
Carbohydr Polym; 2022 Aug; 290():119500. PubMed ID: 35550778
[TBL] [Abstract][Full Text] [Related]
12. Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19.
Anirudhan V; Lee H; Cheng H; Cooper L; Rong L
J Med Virol; 2021 May; 93(5):2722-2734. PubMed ID: 33475167
[TBL] [Abstract][Full Text] [Related]
13. An update on vaccine status and the role of nanomedicine against SARS-CoV-2: A narrative review.
Tajnur R; Rezwan R; Aziz A; Islam MS
Health Sci Rep; 2023 Jul; 6(7):e1377. PubMed ID: 37404449
[TBL] [Abstract][Full Text] [Related]
14. Gallium Components-Based Drug Delivery: A Potential Treatment for COVID-19.
Torabi S; Bahreini F; Rezaei N
Infect Disord Drug Targets; 2022; 22(3):e270122200590. PubMed ID: 35086461
[TBL] [Abstract][Full Text] [Related]
15. Specific delivering of RNAi using Spike's aptamer-functionalized lipid nanoparticles for targeting SARS-CoV-2: A strong anti-Covid drug in a clinical case study.
Saify Nabiabad H; Amini M; Demirdas S
Chem Biol Drug Des; 2022 Feb; 99(2):233-246. PubMed ID: 34714580
[TBL] [Abstract][Full Text] [Related]
16. The role of nanomedicine in COVID-19 therapeutics.
Sharma S
Nanomedicine (Lond); 2022 Feb; 17(3):133-136. PubMed ID: 35012366
[No Abstract] [Full Text] [Related]
17. COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes.
Al-Hatamleh MAI; Hatmal MM; Alshaer W; Rahman ENSEA; Mohd-Zahid MH; Alhaj-Qasem DM; Yean CY; Alias IZ; Jaafar J; Ferji K; Six JL; Uskoković V; Yabu H; Mohamud R
Eur J Pharmacol; 2021 Apr; 896():173930. PubMed ID: 33545157
[TBL] [Abstract][Full Text] [Related]
18. New Drugs Update: Three Novel Treatments for SARS-CoV-2.
Gettman L
Sr Care Pharm; 2022 Aug; 37(8):317-328. PubMed ID: 35879842
[TBL] [Abstract][Full Text] [Related]
19. Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2.
Tammam SN; El Safy S; Ramadan S; Arjune S; Krakor E; Mathur S
J Control Release; 2021 Sep; 337():258-284. PubMed ID: 34293319
[TBL] [Abstract][Full Text] [Related]
20. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
Abdurrahman L; Fang X; Zhang Y
Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
